Back to Search

JENNIFER KING, MA, BCBA

MA, BCBA

Behavior Analyst

NPI: 1255625497Individual

Specialties, Licenses & Credentials

Behavior AnalystPrimary

Behavior Analyst

Code: 103K00000X

1-02-1026(PA)

Clinical Trials (2)

2
Linked Trials
0
Recruiting
2
With Results

Impact of Menstrual Cycle on Antiretroviral Pharmacokinetics in Healthy Women

NCT00869960COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR

The Bioequivalence of Atripla in an Oral Liquid Formulation Compared With the Tablet Formulation in Healthy Volunteers

NCT00862823COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR

Research & Publications (1)

A randomized crossover study to determine relative bioequivalence of tenofovir, emtricitabine, and efavirenz (Atripla) fixed-dose combination tablet compared with a compounded oral liquid formulation derived from the tablet.
PMID 22046602·J Acquir Immune Defic Syndr·2011
4-observational

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
437 E FLORA ST
PHILADELPHIA, PA 19125

Location

Practice Location

437 E FLORA ST, PHILADELPHIA, PA
(215) 432-8991

Quick Facts

NPI
1255625497
Entity Type
Individual
Gender
Female
Medicare
Not confirmed
Specialties
1
Locations
1
Clinical Trials
2
Publications
1

Are you this provider?

Claim Your Profile